Kovaltry

Disruption of the Year: Long-Acting Hemophilia Drugs
BioPharma Dive
Tue, 12/5/17 - 09:34 am
hemophilia
Eloctate
Kovaltry
Bayer
Bioverativ
Germany's Bayer wins U.S. FDA approval for hemophilia A therapy
Yahoo/Reuters
Thu, 03/17/16 - 09:57 am
Bayer
FDA
hemophilia A
Kovaltry
Bayer sees its new Kovaltry as one arrow in a hemophilia quiver
Fierce Pharma Marketing
Wed, 02/24/16 - 09:52 pm
Bayer
Kovaltry
hemophilia